PVG.L Regulatory News (PVG)

15 Jun 2007 14:45

Ark Therapeutics Group PLC15 June 2007 Ark Therapeutics Group plc Director's Share Dealing 15 June 2007: Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company")announces that it was informed today that Professor Seppo YIa-Herttuala, anon-executive director of the Company, sold 500,000 of his Ark ordinary sharesof 1 pence each today to meet his annual Finnish wealth tax liabilities. Theseshares, which represent approximately 0.30% of the Company's issued sharecapital, were sold at a price of 139.25 pence per share. Following thistransaction, Professor YIa-Herttuala will own 3,152,358 Ark ordinary shares,representing 1.89% of the Company's issued share capital. - Ends - This information is provided by RNS The company news service from the London Stock Exchange